However, we noticed that all SGs nucleators (TIA-1, TIAR, G3BP1, G3BP2, and CAPRIN-1) have an “enhancing” effect on cancer development properties [62,64,65,66,67,68,71,72,73], whereas USP10, a SGs inhibitor, has anti-cancer properties [74,75] (Figure 5). The gene discussed is USP10; the disease is cancer.